Unique ID issued by UMIN | UMIN000035878 |
---|---|
Receipt number | R000040880 |
Scientific Title | Study for Autologous Blood-Derived Fibrin Gel (CGF) in Root-end Resection |
Date of disclosure of the study information | 2019/02/15 |
Last modified on | 2019/02/15 17:29:35 |
Study for Autologous Blood-Derived Fibrin Gel (CGF) in Root-end Resection
Utilization of Autologous Blood-Derived Fibrin Gel in Root-end Resection
Study for Autologous Blood-Derived Fibrin Gel (CGF) in Root-end Resection
Utilization of Autologous Blood-Derived Fibrin Gel in Root-end Resection
Japan |
Apical periodontitis
Dental medicine |
Others
NO
To verify positively recovery of alveolar bone lost due to apical periodontitis, we verify the effect of root-end resection combined with CGF which is high bone regeneration inducing ability.
Safety
Dental cone-beam CT imaging at 6 months post operation
Measurement of lesion reduction ratio (dental X-ray photography every 3 months until 12 months post operation).Immediately after surgery, the presence or absence of pain, chest pain and apical tenderness during the follow-up period is judged
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
Central registration
2
Treatment
Medicine |
CGF injection group
non-injection group
20 | years-old | <= |
70 | years-old | >= |
Male and Female
1. Patients who are considered to be effective means of root-end resection for solving the main complaint of the patient and expectation of hope
2. Patients with good overall condition
3. Patients with platelet counts of 100,000 / mm 3 or more
4. Patients aged 20 to 70
5. The consent of research participation is obtained by the document
1. Patients with malignant tumor complicated or having a history
2. Patients with abnormal gingival proliferation or having a history of abnormal gingival proliferation
3. Malignant tumor, premalignant lesion or finding that they are suspected by intraoral diagnosis
4. Patients under 20 or over 70
5. Other patients who are suffering from severe infectious diseases etc. Patients who are judged to be inappropriate for dental practitioners providing this regenerative medicine, etc. from the viewpoint of safety measures etc. to the person who manufactures the following items Consider taking the interview and examination.
(A) Hepatitis B virus (HBV)
(B) Hepatitis C virus (HCV)
(C) Human immunodeficiency virus (HIV)
(D) Human T cell leukemia virus type 1 (HTLV-1)
24
1st name | |
Middle name | |
Last name | Masahiro Saito |
Tohoku University Graduate School of Dentistry
Division of Operative Dentistry
4-1,Seiryo-machi, Aoba-ku,Sendai,Miyagi, Japan
022-717-8340
mssaito@dent.tohoku.ac.jp
1st name | |
Middle name | |
Last name | Masahiro Saito |
Tohoku University Graduate School of Dentistry
Division of Operative Dentistry
4-1,Seiryo-machi, Aoba-ku,Sendai,Miyagi, Japan
022-717-8340
mssaito@dent.tohoku.ac.jp
Japanese Association for Dental Science
Japanese Association for Dental Science
Other
YES
PC2180014
Tohoku Regional Bureau of Health and Welfare
東北大学病院(宮城県)、東京医科歯科大学歯学部付属病院(東京都)、大阪大学歯学部付属病院(大阪府)、新潟大学医歯総合病院(新潟県)
2019 | Year | 02 | Month | 15 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 02 | Month | 14 | Day |
2019 | Year | 02 | Month | 15 | Day |
2019 | Year | 02 | Month | 14 | Day |
2019 | Year | 02 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040880